RiboPro is a biotechnology company that specializes in molecular biology, clinical trials, and health diagnostic services.
RiboPro has raised $2.1M in total funding. The most recent round was Convertible Note. The last funding was announced in January 2024.
RiboPro's investors include Rockstart, BOM, Vlasroot Group, Wietse Mulder, The Fredriks family.
RiboPro is headquartered in Oss, The Netherlands.
RiboPro is a biotechnology company that specializes in molecular biology, clinical trials, and health diagnostic services.
RiboPro is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RiboPro — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/ribopro. Accessed September 15, 2026.
VCBacked. (2024). RiboPro — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/ribopro
{{cite web |title=RiboPro — Funding & Investors |url=https://www.vcbacked.co/company/ribopro |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated